The photocatalytic monofluorination of unactivated alkylarenes, potentially initiated via a single-electron transfer, offers a highly efficient and selective pathway with excellent substrate compatibility, enabling the scale-up synthesis of pharmaceutical molecules. Omitting transition-metal catalysts and photosensitizers simplifies late-stage drug modification and the purification process.